Medical devices, healthcare technology and the business of care
510(k) clearance · K263113

ZSAlign Cervical Interbody System

ZSFab, Inc. · Decision date Oct 2, 2026

MEDTECHLEDGER EXPLANATIONK263113

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision on 02 October 2026 for the ZSAlign Cervical Interbody System, submitted by ZSFab, Inc. of Waltham, Massachusetts, under 510(k) number K263113. The device falls under product code OVE, Intervertebral Fusion Device With Integrated Fixation, Cervical, regulation 888.3080, with the Orthopedic medical specialty and Orthopedic review panel. The application was received 09 September 2026 and was not reviewed by a third party.

A substantially equivalent finding in the 510(k) pathway is a clearance to market, not a premarket approval. The public record identifies the device and its classification but does not describe the specific components, materials, sizes or design changes submitted, nor the predicate device relied upon. The record also does not state indications for use, clinical or bench performance data, or any conditions of clearance; those details would reside in the underlying FDA review documents, which are not included here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Oct 2, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K263113
Regulatory pathway
510(k) premarket notification
Applicant
ZSFab, Inc.
Product code
OVE
Decision code
SESE
Decision date
Oct 2, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Intervertebral Fusion Device With Integrated Fixation, Cervical.

Applicant
ZSFab, Inc.
Product code
OVE
FDA device class
2

FDA decision timeline

  1. K263113 received

    Application receipt date recorded by FDA.

  2. K263113 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code OVE

Product / regulatory recordCompanyPathwayDecision dateSource
Medyssey Co., Ltd.510(k) clearanceSep 29, 2026FDA
Elevation Spine510(k) clearanceSep 23, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

ZSFab, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Waltham, MA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records